On the public citation graph
Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases
0 signed · 121 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2010.563openalex-snapshot
Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa A Randomized Controlled Trial
inferredcites →https://doi.org/10.1001/jama.2013.13805openalex-snapshot
The State of US Health, 1990-2010
inferredcites →https://doi.org/10.1001/jama.2013.1937openalex-snapshot
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis
inferredcites →https://doi.org/10.1001/jama.290.13.1749openalex-snapshot
Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa
inferredcites →https://doi.org/10.1016/j.rmed.2013.05.004openalex-snapshot
A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1016/s0140-6736(02)11081-6openalex-snapshot
Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial
inferredcites →https://doi.org/10.1016/s0140-6736(12)60953-2openalex-snapshot
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(13)61097-1openalex-snapshot
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
inferredcites →https://doi.org/10.1056/nejmoa1104623openalex-snapshot
Azithromycin for Prevention of Exacerbations of COPD
inferredcites →https://doi.org/10.1093/jac/dkq425openalex-snapshot
Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis
inferredcites →https://doi.org/10.1111/all.12199openalex-snapshot
Macrolides for the long-term management of asthma - a meta-analysis of randomized clinical trials
inferredcites →https://doi.org/10.1111/j.1440-1843.2012.02135.xopenalex-snapshot
Low‐dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte‐derived macrophagesin chronic obstructive pulmonary disease subjects
inferredcites →https://doi.org/10.1128/aac.01424-09openalex-snapshot
Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Lung Infection withPseudomonas
inferredcites →https://doi.org/10.1128/cmr.00078-09openalex-snapshot
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
inferredcites →https://doi.org/10.1136/bmj.f1235openalex-snapshot
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
inferredcites →https://doi.org/10.1136/thorax.57.3.212openalex-snapshot
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
inferredcites →https://doi.org/10.1136/thoraxjnl-2012-202698openalex-snapshot
Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
inferredcites →https://doi.org/10.1136/thx.2005.057950openalex-snapshot
Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial
inferredcites →https://doi.org/10.1159/000195915openalex-snapshot
Long-Term Low-Dose Administration of Erythromycin to Patients with Diffuse Panbronchiolitis
inferredcites →https://doi.org/10.1164/rccm.201307-1200ocopenalex-snapshot
Epidemiology of Nontuberculous Mycobacterial Infections and Associated Chronic Macrolide Use among Persons with Cystic Fibrosis
inferredcites →https://doi.org/10.1172/jci46095openalex-snapshot
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
inferredcites →https://doi.org/10.1183/09031936.00062206openalex-snapshot
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
inferredcites →https://doi.org/10.1183/09031936.00095809openalex-snapshot
Azithromycin induces anti-viral responses in bronchial epithelial cells
inferredcites →https://doi.org/10.1186/1471-2180-12-196openalex-snapshot
Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm
inferredcites →https://doi.org/10.1371/journal.pone.0070478openalex-snapshot
Longitudinal Nasopharyngeal Carriage and Antibiotic Resistance of Respiratory Bacteria in Indigenous Australian and Alaska Native Children with Bronchiectasis
inferredcites →https://doi.org/10.3122/jabfm.2012.04.110309openalex-snapshot
Azithromycin for Bronchial Asthma in Adults: An Effectiveness Trial
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3863358openalex-extracted
A Benefit-Harm Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.2139/ssrn.3863359openalex-extracted
Impact of Long-Term Azithromycin Therapy on Carriage and Resistance of Respiratory Bacteria Among Children with HIV-Associated Chronic Lung Disease: A Randomised Controlled Trial
inferred← citeshttps://doi.org/10.1002/jcph.2358openalex-snapshot
Long‐Term Safety Profiles of Macrolides and Tetracyclines: A Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.1007/164_2022_598openalex-snapshot
Precision Medicine in Asthma Therapy
inferred← citeshttps://doi.org/10.1007/978-3-030-76320-6_8openalex-snapshot
Drugs Resistance in Lungs Diseases
inferred← citeshttps://doi.org/10.1007/978-3-031-38495-0_70openalex-snapshot
Antituberculous Agents for Pediatric Mycobacterial Diseases, and Hearing Loss
inferred← citeshttps://doi.org/10.1007/s00408-024-00743-wopenalex-snapshot
Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis
inferred← citeshttps://doi.org/10.1007/s10123-024-00579-7openalex-snapshot
Gallic acid synergistically enhances the antibacterial activity of azithromycin in MRSA
inferred← citeshttps://doi.org/10.1007/s40261-022-01203-0openalex-snapshot
Use of Azithromycin in Pregnancy: More Doubts than Certainties
inferred← citeshttps://doi.org/10.1016/b978-0-444-63407-8.00026-5openalex-snapshot
Miscellaneous Antibacterial Drugs
inferred← citeshttps://doi.org/10.1016/j.amjmed.2015.07.032openalex-snapshot
Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly
inferred← citeshttps://doi.org/10.1016/j.ccc.2024.01.008openalex-snapshot
Prolonged Mechanical Ventilation, Weaning, and the Role of Tracheostomy
inferred← citeshttps://doi.org/10.1016/j.chest.2024.06.003openalex-snapshot
A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112739openalex-snapshot
Azithromycin: The First Broad-spectrum Therapeutic
inferred← citeshttps://doi.org/10.1016/j.healun.2020.09.006openalex-snapshot
Azithromycin prophylaxis after lung transplantation is associated with improved overall survival
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.123841openalex-snapshot
Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection
inferred← citeshttps://doi.org/10.1016/j.ijporl.2021.110808openalex-snapshot
Effects of long-term azithromycin therapy on auditory functions in children with chronic respiratory diseases
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2018.09.014openalex-snapshot
The reporting of safety among drug systematic reviews was poor before the implementation of the PRISMA harms checklist
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2024.111509openalex-snapshot
Stakeholder-informed positivity thresholds for disease markers and risk scores: a methodological framework and an application in obstructive lung disease
inferred← citeshttps://doi.org/10.1016/j.jtauto.2020.100062openalex-snapshot
WITHDRAWN: Azithromycin: The First Broad-spectrum Therapeutic
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2014.03.003openalex-snapshot
Azithromycin: Mechanisms of action and their relevance for clinical applications
inferred← citeshttps://doi.org/10.1016/j.psycr.2023.100136openalex-snapshot
Management of upper gastrointestinal manifestations of clozapine-induced gut hypomotility: Challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.resinv.2023.12.015openalex-snapshot
Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.rmed.2026.108886openalex-snapshot
Malnutrition in childhood interstitial lung diseases is associated with reduced lung function and greater disease severity: insights from the chILD-EU registry
inferred← citeshttps://doi.org/10.1038/s41467-026-76867-9openalex-snapshot
Impact of the anti-inflammatory macrolide glasmacinal on the gut microbiota of healthy adults: an open-label trial
inferred← citeshttps://doi.org/10.1038/s41598-017-13034-7openalex-snapshot
Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae
inferred← citeshttps://doi.org/10.1038/s41598-021-91089-3openalex-snapshot
Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1038/s41598-023-39647-9openalex-snapshot
In vitro synergy screens of FDA-approved drugs reveal novel zidovudine- and azithromycin-based combinations with last-line antibiotics against Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1080/00325481.2017.1285677openalex-snapshot
Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician
inferred← citeshttps://doi.org/10.1080/09581596.2026.2692158openalex-snapshot
Prophylactic azithromycin for chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized clinical trials
inferred← citeshttps://doi.org/10.1080/15412555.2025.2532076openalex-snapshot
Current Practices on Prescribing and Deprescribing for Patients on Long-Term Antibiotic Treatment for Chronic Pulmonary Conditions: An Umbrella Review by the European Society of Clinical Pharmacy (ESCP)
inferred← citeshttps://doi.org/10.1093/ced/llag346openalex-snapshot
Pulsed azithromycin for the treatment of dacomitinib-induced skin toxicity in a patient with tetracycline intolerance: a case report
inferred← citeshttps://doi.org/10.1093/jac/dky174openalex-snapshot
Life-long antimicrobial therapy: where is the evidence?
inferred← citeshttps://doi.org/10.1093/ofid/ofaf788openalex-snapshot
Clinical Characteristics and Management of Non-Tuberculous Mycobacterial Skin and Soft Tissue Infections: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1101/2022.07.03.498633openalex-snapshot
Repurposing azithromycin in combination with last-line fosfomycin, colistin and tigecycline against Multi-Drug Resistant Klebsiella pneumoniae
inferred← citeshttps://doi.org/10.1111/ajt.13417openalex-snapshot
Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial
inferred← citeshttps://doi.org/10.1111/crj.12278openalex-snapshot
Efficacy and safety of long‐term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta‐analysis
inferred← citeshttps://doi.org/10.1111/ctr.12401openalex-snapshot
Azithromycin improves lung function in patients with post‐lung transplant bronchiolitis obliterans syndrome: a meta‐analysis
inferred← citeshttps://doi.org/10.1111/ctr.14832openalex-snapshot
Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience
inferred← citeshttps://doi.org/10.1111/ijpp.12670openalex-snapshot
Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association
inferred← citeshttps://doi.org/10.1128/aac.02904-14openalex-snapshot
Development of a Population Pharmacokinetic Model Characterizing the Tissue Distribution of Azithromycin in Healthy Subjects
inferred← citeshttps://doi.org/10.1128/aac.04447-14openalex-snapshot
Relationship between Azithromycin Susceptibility and Administration Efficacy for Nontypeable Haemophilus influenzae Respiratory Infection
inferred← citeshttps://doi.org/10.1136/bmj-2026-100111openalex-snapshot
Comparative effectiveness of azithromycin versus roflumilast in patients with chronic obstructive pulmonary disease: emulated target trial
inferred← citeshttps://doi.org/10.1136/thorax-2024-222396openalex-snapshot
Antimicrobial resistance in chronic lung infection: the road to resistance
inferred← citeshttps://doi.org/10.1136/thoraxjnl-2019-213929openalex-snapshot
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
inferred← citeshttps://doi.org/10.1136/thoraxjnl-2019-214039openalex-snapshot
BTS guideline on long-term macrolides in adults with respiratory disease: not quite a panacea
inferred← citeshttps://doi.org/10.1136/thoraxjnl-2021-217962openalex-snapshot
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1136/vr.105260openalex-snapshot
Randomised study of the immunomodulatory effects of azithromycin in severely asthmatic horses
inferred← citeshttps://doi.org/10.1155/2019/2346583openalex-snapshot
Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety
inferred← citeshttps://doi.org/10.1155/2023/2596562openalex-snapshot
Efficacy and Safety of Integrated Maxing Shigan Decoction and Azithromycin for Mycoplasma Pneumoniae Pneumonia in Children: A Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.11575/prism/28098openalex-snapshot
The Effects of Azithromycin on Dextran Sulfate Sodium Colitis in Mice
inferred← citeshttps://doi.org/10.1159/000445151openalex-snapshot
Oral Therapeutics for Rhinosinusitis with Nasal Polyposis
inferred← citeshttps://doi.org/10.1159/000541447openalex-snapshot
The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis
inferred← citeshttps://doi.org/10.1164/rccm.201901-0094ocopenalex-snapshot
Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial
inferred← citeshttps://doi.org/10.1165/rcmb.2025-0085ocopenalex-snapshot
Construction of an Indole-induced Transgenic System and Its Therapeutic Effects on Allergic Rhinitis
inferred← citeshttps://doi.org/10.1177/17557380261428045openalex-snapshot
Childhood interstitial lung diseases
inferred← citeshttps://doi.org/10.1177/2515841418783622openalex-snapshot
An eye for azithromycin: review of the literature
inferred← citeshttps://doi.org/10.1183/23120541.00491-2021openalex-snapshot
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease
inferred← citeshttps://doi.org/10.1183/23120541.00792-2025openalex-snapshot
Azithromycin in lung transplantation: revisiting its dual role from prophylaxis to therapy
inferred← citeshttps://doi.org/10.1186/s12879-015-0872-5openalex-snapshot
Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1186/s12889-022-13962-8openalex-snapshot
Self-medication and ILI etiologies among individuals presenting at pharmacies with influenza-like illness: Guatemala City, 2018 influenza season
inferred← citeshttps://doi.org/10.1186/s13756-020-00783-wopenalex-snapshot
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin
inferred← citeshttps://doi.org/10.1186/s40168-026-02440-7openalex-snapshot
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor–tezacaftor–ivacaftor therapy
inferred← citeshttps://doi.org/10.1513/annalsats.201812-882ocopenalex-snapshot
Quantifying Long-Term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis
inferred← citeshttps://doi.org/10.1513/annalsats.202304-301ocopenalex-snapshot
A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
inferred← citeshttps://doi.org/10.1586/14787210.2014.952282openalex-snapshot
Antimicrobial treatment of non-cystic fibrosis bronchiectasis
inferred← citeshttps://doi.org/10.18053/jctres.07.202102.002openalex-snapshot
Addressing the global surge of COVID-19 cases: Insights from diagnostics, improved treatment strategies, vaccine development and application
inferred← citeshttps://doi.org/10.18773/austprescr.2015.030openalex-snapshot
Prescribing azithromycin
inferred← citeshttps://doi.org/10.21037/jtd.2017.11.85openalex-snapshot
Prevention of chronic rejection after lung transplantation
inferred← citeshttps://doi.org/10.2147/copd.s550636openalex-snapshot
Clinical and Economic Burden of COPD in Patients on Inhaled Triple Therapy in Germany – A Retrospective Claims Data Analysis
inferred← citeshttps://doi.org/10.2174/156802662108210319145317openalex-snapshot
Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance
inferred← citeshttps://doi.org/10.21876/rcshci.v11i4.1184openalex-snapshot
A critical analysis about the supposed role of azithromycin in the treatment of covid-19
inferred← citeshttps://doi.org/10.22037/ijpr.2020.113821.14506openalex-snapshot
Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review.
inferred← citeshttps://doi.org/10.25560/69790openalex-snapshot
Pharmacokinetics of stilbene analogues and their application as novel anti-inflammatory agents for chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.3329/bjms.v20i3.52794openalex-snapshot
Azithromycin and Co-Trimoxazole in Antimicrobial Prophylaxis: Special Emphasis on Primary Immunodeficiencies in Children
inferred← citeshttps://doi.org/10.33590/emj/10310522openalex-snapshot
Slowing Progression of Airway Diseases by Smoking Cessation and Reducing Infections
inferred← citeshttps://doi.org/10.3389/fenvs.2022.940975openalex-snapshot
Environmental and ecotoxicological effects of drugs used for the treatment of COVID 19
inferred← citeshttps://doi.org/10.3389/fneur.2021.652674openalex-snapshot
Ototoxicity of Non-aminoglycoside Antibiotics
inferred← citeshttps://doi.org/10.3389/fpubh.2023.1123555openalex-snapshot
Relationships between antibiotic exposure and asthma in adults in the United States: results of the National Health and Nutrition Examination Survey between 1999 and 2018
inferred← citeshttps://doi.org/10.3389/froh.2025.1544821openalex-snapshot
Effects of combined cyclosporin and azithromycin treatment on human mononuclear cells under lipopolysaccharide challenge
inferred← citeshttps://doi.org/10.3389/ti.2026.16959openalex-snapshot
European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction
inferred← citeshttps://doi.org/10.3390/antibiotics13121176openalex-snapshot
“Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases
inferred← citeshttps://doi.org/10.3390/antibiotics8030110openalex-snapshot
Mitochondrial Toxicity of Azithromycin Results in Aerobic Glycolysis and DNA Damage of Human Mammary Epithelia and Fibroblasts
inferred← citeshttps://doi.org/10.3390/biom9120891openalex-snapshot
Preclinical Evaluation of the Antimicrobial-Immunomodulatory Dual Action of Xenohormetic Molecules against Haemophilus influenzae Respiratory Infection
inferred← citeshttps://doi.org/10.3390/ijms21155224openalex-snapshot
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
inferred← citeshttps://doi.org/10.3390/medicina61040653openalex-snapshot
Efficacy of Long-Term Use of Azithromycin in the Management of Cystic Fibrosis in Pediatric Patients with or Without Pseudomonas aeruginosa: A Systematic Review and Meta-Analysis Article
inferred← citeshttps://doi.org/10.3390/ph16010052openalex-snapshot
Azithromycin Mitigates Cisplatin-Induced Lung Oxidative Stress, Inflammation and Necroptosis by Upregulating SIRT1, PPARγ, and Nrf2/HO-1 Signaling
inferred← citeshttps://doi.org/10.3889/oamjms.2020.5615openalex-snapshot
Complications of Coronavirus Disease-19 in a Hospitalized Patient: A Case Report
inferred← citeshttps://doi.org/10.3949/ccjm.84a.16123openalex-snapshot
Which patients with respiratory disease need long-term azithromycin?
inferred← citeshttps://doi.org/10.4103/lungindia.lungindia_498_19openalex-snapshot
Expert recommendations on the role of macrolides in chronic respiratory diseases
inferred← citeshttps://doi.org/10.4103/njpt.njpt_33_24openalex-snapshot
Bullous fixed drug eruption due to azithromycin: A rare case report
inferred← citeshttps://doi.org/10.4187/respcare.05957openalex-snapshot
Medication Regimens for Managing Stable Asthma
inferred← citeshttps://doi.org/10.47583/ijpsrr.2023.v80i02.019openalex-snapshot
Development and Validation of Liquid Chromatography Method for Determination of Tepotinib in Bulk Drug and in Tablet Dosage Form
inferred← citeshttps://doi.org/10.5578/tt.20219610openalex-snapshot
Long-term macrolide therapy in asthma
inferred← citeshttps://doi.org/10.6084/m9.figshare.20484769openalex-snapshot
Additional file 1 of Self-medication and ILI etiologies among individuals presenting at pharmacies with influenza-like illness: Guatemala City, 2018 influenza season
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.